High-dose chemotherapy in a patient with coronavirus disease (COVID-19)

The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an unprecedented challenge [1]. High-dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) represents a potentially curative option for testicular germ cell tumour (TGCT) [2]; however, to our knowledge, to date, there have been no reports on these regimens in patients with COVID-19.

Source: European Journal of Cancer - July 3, 2020 Category: Cancer & Oncology Authors: Ugo De Giorgi, Chiara Casadei, Giuseppe Bronte, Mattia Altini, Giovani Martinelli Tags: Letter to the Editor Source Type: research